web analytics
Expertise in pharmaceutical development provides clients with solutions | Velesco Pharma

Analytical Development Case Studies | Velesco Pharma

Expert Solutions to Challenging Analytical Development Scenarios



Challenge: method development and validation for a challenging drug product


Velesco was employed to develop a Phase 3 method for drug quantitation at multiple strengths, preservative quantitation and impurity analysis from a method designed for an active pharmaceutical ingredient (API) with co-eluting preservative related impurity peaks. This proved challenging due to difficulty with the compound and the inability to use a single-point standard curve. Velesco was able to meet our client's needs and provided a Phase 3 HPLC method and HPLC method validation for multiple strengths of drug product.

Read the analytical development case study



Challenge: extraction of difficult compounds


Velesco updated HPLC drug product methods to quantify API and preservative in new pharmaceutical formulations containing excipients that were challenging to extract using the existing methods. We swiftly determined the causes of extraction inconsistencies and updated the analytical methods to remedy the issues.

Read the analytical development case studies



Challenge: large potential dose range


Analytical method development for multiple strengths of a difficult compound in a very large dosing range can be a challenge, but with Velesco, our clients' needs are met consistently and quickly.

Read the analytical development case study



Challenge: quick turnaround time required


Velesco applies nimblocity to develop analytical methods and formulations for clients - reflecting Velesco's commitment to be responsive, accommodating and eager to help clients reach the full potential of their compound, quickly and efficiently.

Read the analytical development case study


nimblocity reflects Velesco Pharmaceutical Services' commitment to be responsive, accommodating and eager to help you reach the full potential of your compound, quickly and efficiently

News and Events

Pace® Life Sciences Acquires Velesco Pharmaceutical Services, Expanding Capabilities in Drug Development Services

Read the Press Release!

Dave Barnes, Ph.D. CEO/CSO is a featured speaker for the webinar Topical Formulation: Selection of Excipients and Better Process Understanding for Success in Commercial Manufacturing. Webinar recording available now.

View Recording!

Newly Acquired DEA Analytical Laboratory License. We are licensed to use schedules 2, 2N, 3, 3N, 4, and 5.

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Gerry Cox, Founder and Chief Operating Officer at Velesco Pharmaceutical Services.

Roundtable: M&A trends in CDMO - Molecule to Market

New Velesco Pharma clinical manufacturing facility begins operations.

Read the press release here.

Lisa Crandall, MS, and Peter Angus, PhD, spoke with Pharmaceutical Technology about the best practices in stability testing.

Read the interview here.

Velesco has expanded our analytical facilities in a new Wixom, Michigan location with the help of the Bank of Ann Arbor Technology Industry Group.

Read the press release here.

CEO Dave Barnes has been published in a new Pharmoutsourcing article on Clinical Trial Materials and Manufacturing!

1 new job postings! Careers

Velesco's work published

Formulation Development & Manufacturing:
Using a Single Provider Reduces Costs & Risk
Read it here.

Follow Velesco

LinkedIn IN Icon 25px Google+ Follow VelescoPharma on Twitter FB FindUsOnFacebook 100